--- title: "Fresenius SE & Co. KGaA (FRE) stock and investor profile" url: "https://aibio.space/companies/fresenius/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Fresenius SE & Co. KGaA (XETR: FRE), Germany. The directory classifies it as Diversified pharmaceuticals/medtech." --- FRE Fresenius SE & Co. KGaA XETR · Germany # Fresenius SE & Co. KGaA (FRE) news Debt Financing · 2026-07-01 ## [Fresenius issues €1 billion in dual-tranche bonds](https://aibio.space/news/fresenius-issues-1-billion-dual-tranche-bonds/) Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing. ## Latest Fresenius SE & Co. KGaA news We have not published a story on Fresenius SE & Co. KGaA yet. When there is news, it will appear here. ## Fresenius SE & Co. KGaA at a glance - **Ticker**: FRE - **Listing**: XETR - **Country**: Germany ### Related companies - [Immatics](https://aibio.space/companies/immatics-n-v/) NASDAQ: IMTX - [Bayer](https://aibio.space/companies/bayer/) XETR: BAYN - [Formycon](https://aibio.space/companies/formycon/) XETR: FYB - [Merck KGaA](https://aibio.space/companies/merck-mrk-xetr/) XETR: MRK - [Dermapharm Holding](https://aibio.space/companies/dermapharm/) XETR: DMP - [Vivoryon Therapeutics](https://aibio.space/companies/vivoryon-therapeutics-n-v/) EURONEXT: VVY - [Evotec](https://aibio.space/companies/evotec/) XETR: EVT - [BRAIN Biotech](https://aibio.space/companies/brain-biotech/) XETR: BNN ### Also on XETR - [Novogenia](https://aibio.space/companies/novogenia/) 7V0 - [Heidelberg Pharma](https://aibio.space/companies/heidelberg-pharma/) HPHA - [Bayer](https://aibio.space/companies/bayer/) BAYN - [Merck KGaA](https://aibio.space/companies/merck-mrk-xetr/) MRK - [Biofrontera](https://aibio.space/companies/biofrontera-b8fk/) B8FK - [Bio-Gate](https://aibio.space/companies/bio-gate/) BIG ## Questions about Fresenius SE & Co. KGaA What is the ticker symbol of Fresenius SE & Co. KGaA? Fresenius SE & Co. KGaA trades under the ticker FRE on XETR. Where is Fresenius SE & Co. KGaA listed? Fresenius SE & Co. KGaA is listed on XETR. Which country or territory is Fresenius SE & Co. KGaA listed under? Our directory records Fresenius SE & Co. KGaA under Germany. What does Fresenius SE & Co. KGaA do? Our directory classifies Fresenius SE & Co. KGaA as: Diversified pharmaceuticals/medtech. This is a directory classification, not a description of the pipeline. What is the ISIN of Fresenius SE & Co. KGaA? The ISIN recorded for Fresenius SE & Co. KGaA is DE000FRE5EN2. Does aibio.space cover Fresenius SE & Co. KGaA? aibio.space lists Fresenius SE & Co. KGaA among 2,820 public biotech companies and publishes its news here as stories appear. What is the latest Fresenius SE & Co. KGaA (FRE) stock news? Our latest story on Fresenius SE & Co. KGaA, dated Jul 1, 2026: "Fresenius issues €1 billion in dual-tranche bonds". Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing. [Source](https://aibio.space/news/fresenius-issues-1-billion-dual-tranche-bonds/). Does Fresenius SE & Co. KGaA have debt, a term loan or convertible notes? Our latest debt story, dated Jul 1, 2026: "Fresenius issues €1 billion in dual-tranche bonds". Two €500 million tranches, due in 2031 and 2034, will fund general corporate purposes, including refinancing. [Source](https://aibio.space/news/fresenius-issues-1-billion-dual-tranche-bonds/). Which companies are similar to Fresenius SE & Co. KGaA? Companies in our directory listed in the same country and business area as Fresenius SE & Co. KGaA: Immatics, Bayer, Formycon, Merck KGaA, Dermapharm Holding, Vivoryon Therapeutics. How can I follow Fresenius SE & Co. KGaA (FRE) news? Press Follow on this page to add Fresenius SE & Co. KGaA to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Fresenius SE & Co. KGaA so far, in Debt Financing. ## Investor discussion: Fresenius SE & Co. KGaA Members talk about Fresenius SE & Co. KGaA (FRE). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open XETR:FRE on TradingView](https://www.tradingview.com/symbols/XETR-FRE/). ## Listing details Fresenius SE & Co. KGaA is a public biotech or pharmaceutical company listed on XETR under the ticker FRE, recorded under Germany. The directory classifies it as Diversified pharmaceuticals/medtech. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Fresenius SE & Co. KGaA - **Ticker**: FRE - **Listing**: XETR - **Country or territory**: Germany - **Business scope**: Diversified pharmaceuticals/medtech - **ISIN**: DE000FRE5EN2 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.fresenius.com/taxonomy/term/3) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/fresenius/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Fresenius SE & Co. KGaA (FRE) stock and investor profile", 2026-10-31, https://aibio.space/companies/fresenius/